康恩貝(600572.SH)擬對健康科技公司等比例增資4800萬元
格隆匯3月19日丨康恩貝(600572.SH)公佈,為進一步加快推進大健康產業佈局,增強浙江康恩貝健康科技有限公司(以下簡稱“健康科技公司”,公司持有80%股權)的資金實力和運營能力,推動健康科技公司高質量發展,公司與健康科技公司其他原股東擬按持股比例對健康科技公司進行增資。
健康科技公司現註冊資本3000萬元,本次健康科技公司擬增資6000萬元,其中增加註冊資本2500萬元,由原股東各按持股比例認繳,其中公司擬以現金4800萬元認繳新增註冊資本2000萬元,剩餘2800萬元計入資本公積。本次增資事項構成關聯交易事項。
健康科技公司主要通過國內各大電商平台銷售“康恩貝”、“寶芝林”、“養營堂”三大品牌系列產品,銷售模式主要包括B2C(自營店鋪直銷)、B2B(寄售、渠道銷售)和線上經銷商模式。2020年1月以來已上線前列康、腸炎寧、金笛等OTC系列藥品,健康科技保健食品以及寶芝林傳統滋補品等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.